Pacira Pharmaceuticals buy Wedbush
Start price
08.02.24
/
50%
€25.80
Target price
08.02.25
€53.03
Performance (%)
-0.78%
End price
09.02.25
€25.60
Summary
This prediction ended on 09.02.25 with a price of €25.60. During the runtime of the prediction for Pacira Pharmaceuticals the price only changed by -0.78%. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 4.717% | 4.717% | 19.355% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Wedbush for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Wedbush gewählte maximale Laufzeit wurde überschritten